Endocannabinoid-mediated control of synaptic transmission.

The discovery of cannabinoid receptors and subsequent identification of their endogenous ligands (endocannabinoids) in early 1990s have greatly accelerated research on cannabinoid actions in the brain. Then, the discovery in 2001 that endocannabinoids mediate retrograde synaptic signaling has opened up a new era for cannabinoid research and also established a new concept how diffusible messengers modulate synaptic efficacy and neural activity. The last 7 years have witnessed remarkable advances in our understanding of the endocannabinoid system. It is now well accepted that endocannabinoids are released from postsynaptic neurons, activate presynaptic cannabinoid CB(1) receptors, and cause transient and long-lasting reduction of neurotransmitter release. In this review, we aim to integrate our current understanding of functions of the endocannabinoid system, especially focusing on the control of synaptic transmission in the brain. We summarize recent electrophysiological studies carried out on synapses of various brain regions and discuss how synaptic transmission is regulated by endocannabinoid signaling. Then we refer to recent anatomical studies on subcellular distribution of the molecules involved in endocannabinoid signaling and discuss how these signaling molecules are arranged around synapses. In addition, we make a brief overview of studies on cannabinoid receptors and their intracellular signaling, biochemical studies on endocannabinoid metabolism, and behavioral studies on the roles of the endocannabinoid system in various aspects of neural functions.

[1]  P. Mitchell,et al.  Depression and anxiety with rimonabant , 2007, The Lancet.

[2]  D. Feldman,et al.  Long-term depression induced by sensory deprivation during cortical map plasticity in vivo , 2003, Nature Neuroscience.

[3]  A. Levey,et al.  Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus , 2000, Neuroscience Letters.

[4]  J. D. Richardson,et al.  Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia , 1998, The Journal of Neuroscience.

[5]  J. Rossier,et al.  Absolute quantification of AMPA receptor subunit mRNAs in single hippocampal neurons , 2001, Journal of neurochemistry.

[6]  L. Petrocellis,et al.  N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. , 2000, The Biochemical journal.

[7]  K. Connolly,et al.  Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids , 2001, Neuroscience Letters.

[8]  C. Hillard,et al.  The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. , 2000, Chemistry and physics of lipids.

[9]  W. Regehr,et al.  Endocannabinoids Inhibit Transmission at Granule Cell to Purkinje Cell Synapses by Modulating Three Types of Presynaptic Calcium Channels , 2004, The Journal of Neuroscience.

[10]  D. Tregouet,et al.  Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  M. Christie,et al.  Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro , 2001, The Journal of physiology.

[12]  N. Stella,et al.  Receptor-dependent formation of endogenous cannabinoids in cortical neurons. , 2001, European journal of pharmacology.

[13]  Yue Wang,et al.  Induction of LTD in the dentate gyrus in vitro is NMDA receptor independent, but dependent on Ca2+ influx via low-voltage-activated Ca2+ channels and release of Ca2+ from intracellular stores. , 1997, Journal of neurophysiology.

[14]  G. Marsicano,et al.  Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain , 2002, Neuroscience.

[15]  J. Crystal,et al.  An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.

[16]  M. Kano,et al.  Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release , 2008, Neuropharmacology.

[17]  J. Lacaille,et al.  Cell‐type specific GABA synaptic transmission and activity‐dependent plasticity in rat hippocampal stratum radiatum interneurons , 2005, The European journal of neuroscience.

[18]  K. Mackie,et al.  Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors , 2007, Nature Neuroscience.

[19]  D. Macneil,et al.  Distribution of orexin receptor mRNA in the rat brain , 1998, FEBS letters.

[20]  B. Koller,et al.  Altered inflammatory responses in leukotriene-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Mackie,et al.  The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. B. Roberts,et al.  Suppression of NMDA receptor function using antisense DNA block ocular dominance plasticity while preserving visual responses. , 1998, Journal of neurophysiology.

[23]  J. Shim,et al.  CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. , 2002, Chemistry and physics of lipids.

[24]  Masahiko Watanabe,et al.  Depolarization‐induced suppression of inhibition mediated by endocannabinoids at synapses from fast‐spiking interneurons to medium spiny neurons in the striatum , 2006, The European journal of neuroscience.

[25]  C. Funk,et al.  Disruption of 12/15-Lipoxygenase Expression in Peritoneal Macrophages , 1996, The Journal of Biological Chemistry.

[26]  S. Nakanishi,et al.  Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. , 1992, The Journal of biological chemistry.

[27]  K Williams,et al.  Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. , 1993, Molecular pharmacology.

[28]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[29]  A. Schierloh,et al.  Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission , 2006, The Journal of Neuroscience.

[30]  L. Petrocellis,et al.  Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain , 2008, Neuroscience.

[31]  E. Marco,et al.  Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats , 2003, Pharmacology Biochemistry and Behavior.

[32]  Stephen P. H. Alexander,et al.  Influence of Cannabinoids on Electrically Evoked Dopamine Release and Cyclic AMP Generation in the Rat Striatum , 1997, Journal of neurochemistry.

[33]  M. Storozhuk,et al.  Presence of depolarization-induced suppression of inhibition in a fraction of GABAergic synaptic connections in rat neocortical cultures. , 2005, Neuroscience and behavioral physiology.

[34]  J. Rossier,et al.  Cerebral Cortex doi:10.1093/cercor/bhj081 Cortical Sources of CRF, NKB, and CCK and Their Effects on Pyramidal Cells , 2005 .

[35]  S. Snyder,et al.  Differential immunohistochemical localization of inositol 1,4,5- trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  P. Somogyi,et al.  The metabotropic glutamate receptor (mGluRlα) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction , 1993, Neuron.

[37]  P. J. Sjöström,et al.  Rate, Timing, and Cooperativity Jointly Determine Cortical Synaptic Plasticity , 2001, Neuron.

[38]  Masahiko Watanabe,et al.  Signaling complex formation of phospholipase Cβ4 with metabotropic glutamate receptor type 1α and 1,4,5‐trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain , 2004, The European journal of neuroscience.

[39]  T. Freund,et al.  Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology , 2004, Hippocampus.

[40]  J. Barker,et al.  Functional properties of ryanodine receptors in hippocampal neurons change during early differentiation in culture. , 2002, Journal of neurophysiology.

[41]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[42]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[43]  J. Rossier,et al.  Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel , 1994, Neuron.

[44]  M. Morales,et al.  Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5‐HT3A) are co‐expressed in GABA neurons in the rat telencephalon , 2004, The Journal of comparative neurology.

[45]  G. Milligan,et al.  Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function* , 2006, Journal of Biological Chemistry.

[46]  D. Lovinger,et al.  Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. , 2001, Journal of neurophysiology.

[47]  A. Grace,et al.  The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction , 2006, Cellular and Molecular Life Sciences CMLS.

[48]  Pankaj Sah,et al.  Nuclear Calcium Signaling Evoked by Cholinergic Stimulation in Hippocampal CA1 Pyramidal Neurons , 2002, The Journal of Neuroscience.

[49]  G. Uhl,et al.  Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain , 2006, Brain Research.

[50]  W. Yung,et al.  Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist , 1998, Neuroreport.

[51]  I. Llano,et al.  The retrograde inhibition of IPSCs in rat cerebellar Purkinje cells is highly sensitive to intracellular Ca2+ , 2000, The European journal of neuroscience.

[52]  W. Regehr,et al.  Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses , 2008, The Journal of Neuroscience.

[53]  M. Bear,et al.  Synaptic plasticity: LTP and LTD , 1994, Current Opinion in Neurobiology.

[54]  Masahiko Watanabe,et al.  The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynaptic Sites in the Hippocampus and Cerebellum , 2006, The Journal of Neuroscience.

[55]  R. Hampson,et al.  Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats , 2008, Psychopharmacology.

[56]  C. Vaughan,et al.  Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro , 2004, Neuropharmacology.

[57]  S. Treistman,et al.  Distinct intracellular calcium profiles following influx through N- versus L-type calcium channels: role of Ca2+-induced Ca2+ release. , 2004, Journal of neurophysiology.

[58]  T. Yoshioka,et al.  Calcium-independent inhibition of GABAA current by caffeine in hippocampal slices , 2004, Brain Research.

[59]  Yuriy Pankratov,et al.  Somatodendritic Release of Glutamate Regulates Synaptic Inhibition in Cerebellar Purkinje Cells via Autocrine mGluR1 Activation , 2007, The Journal of Neuroscience.

[60]  M. Kathmann,et al.  Modulation of transmitter release via presynaptic cannabinoid receptors. , 2001, Trends in pharmacological sciences.

[61]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Kombian,et al.  Dendritically Released Peptides Act as Retrograde Modulators of Afferent Excitation in the Supraoptic Nucleus In Vitro , 1997, Neuron.

[63]  K. Mackie,et al.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.

[64]  F. Pamplona,et al.  WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors , 2006, Neuroscience Letters.

[65]  L. Abbott,et al.  Competitive Hebbian learning through spike-timing-dependent synaptic plasticity , 2000, Nature Neuroscience.

[66]  L. Garey,et al.  Distribution of preprosomatostatin mRNA in the rat parietal and temporal cortex. , 1994, Brain research. Molecular brain research.

[67]  Beat Lutz,et al.  The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.

[68]  J. Hoenicka,et al.  Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) , 2005, The Pharmacogenomics Journal.

[69]  David Robbe,et al.  A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity , 2004, Nature Neuroscience.

[70]  R. Maldonado,et al.  Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol , 2002, Psychopharmacology.

[71]  S. File,et al.  Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats , 2004, Behavioural pharmacology.

[72]  Raphael Mechoulam,et al.  CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition , 2005 .

[73]  D. Lovinger,et al.  Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Kano,et al.  Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.

[75]  Masahiko Watanabe,et al.  Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2‐mediated direct suppression and M1/M3‐mediated indirect suppression through endocannabinoid signalling , 2004, The European journal of neuroscience.

[76]  W. Yung,et al.  Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium , 1998, Neuroscience Letters.

[77]  Michael Häusser,et al.  Dendritic Calcium Spikes Are Tunable Triggers of Cannabinoid Release and Short-Term Synaptic Plasticity in Cerebellar Purkinje Neurons , 2006, The Journal of Neuroscience.

[78]  D. Piomelli,et al.  Carrier‐mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2‐arachidonylglycerol , 2000, Neuroreport.

[79]  Takaaki AbeS,et al.  Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR 5 Coupled to Inositol Phosphate / Ca 2 + Signal Transduction , 2001 .

[80]  B. Alger,et al.  Direct depolarization and antidromic action potentials transiently suppress dendritic IPSPs in hippocampal CA1 pyramidal cells. , 2001, Journal of neurophysiology.

[81]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[82]  D. Deutsch,et al.  Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry , 1998, Neuroscience Letters.

[83]  Frank Kirchhoff,et al.  Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation. , 2006, Journal of neurophysiology.

[84]  D. Clapham,et al.  Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator Fluo-3. , 1997, Cell calcium.

[85]  K. Starke,et al.  Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum , 1998, Neuroscience.

[86]  J. Flier,et al.  Obesity and the Hypothalamus: Novel Peptides for New Pathways , 1998, Cell.

[87]  C. Ashby,et al.  Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. , 1996, The Journal of pharmacology and experimental therapeutics.

[88]  K. Mackie,et al.  Metabotropic suppression of excitation in murine autaptic hippocampal neurons , 2007, The Journal of physiology.

[89]  I. Soltesz,et al.  Cell type–specific gating of perisomatic inhibition by cholecystokinin , 2007, Nature Neuroscience.

[90]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[91]  David A Lewis,et al.  Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. , 2006, Cerebral cortex.

[92]  V. Marzo,et al.  Cannabinoid receptors and their role in neuroprotection , 2007, NeuroMolecular Medicine.

[93]  J. Palacios,et al.  The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution , 1990, Neuroscience.

[94]  H. Markram,et al.  Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat , 2004, The Journal of physiology.

[95]  H. Ueda,et al.  A Possible Pathway of Phosphoinositide Metabolism Through EDTA‐Insensitive Phospholipase A1 Followed by Lysophosphoinositide‐Specific Phospholipase C in Rat Brain , 1993, Journal of neurochemistry.

[96]  A. Ottani,et al.  Learning Impairment Produced in Rats by the Cannabinoid Agonist HU 210 in a Water-Maze Task , 1999, Pharmacology Biochemistry and Behavior.

[97]  C. Breivogel,et al.  Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. , 2001, Molecular pharmacology.

[98]  J. Manzanares,et al.  Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors , 2004, Neuropharmacology.

[99]  N. Volkow,et al.  123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. , 1996, European journal of pharmacology.

[100]  R. Hawkins,et al.  Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. , 2002, Journal of neurophysiology.

[101]  G. Perrault,et al.  SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats , 2002, Behavioural pharmacology.

[102]  Anatol C. Kreitzer,et al.  Inhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum , 2002, Neuron.

[103]  David E Nichols,et al.  Serotonin 5‐HT2A receptor activation induces 2‐arachidonoylglycerol release through a phospholipase c‐dependent mechanism , 2006, Journal of neurochemistry.

[104]  K. Mackie,et al.  Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line , 2008, British journal of pharmacology.

[105]  H. Markram,et al.  Neuropeptide and calcium‐binding protein gene expression profiles predict neuronal anatomical type in the juvenile rat , 2005, The Journal of physiology.

[106]  K. Mackie,et al.  A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization , 2007, Molecular Pharmacology.

[107]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[108]  S. Snyder,et al.  Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[109]  P. Schweitzer Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons , 2000, The Journal of Neuroscience.

[110]  P. Schweitzer,et al.  Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus , 2005, Neuropharmacology.

[111]  M. Isokawa,et al.  Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus , 2002, The Journal of Neuroscience.

[112]  C. Yamamoto,et al.  Properties of depolarization-induced suppression of inhibitory transmission in cultured rat hippocampal neurons , 1997, Pflügers Archiv.

[113]  Masahiko Watanabe,et al.  Tonic Enhancement of Endocannabinoid-Mediated Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in the Striatum , 2007, The Journal of Neuroscience.

[114]  S. Di,et al.  Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. , 2005, Endocrinology.

[115]  Wade G Regehr,et al.  Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids , 2003, Nature Neuroscience.

[116]  D. Woodward,et al.  Prostamides (prostaglandin‐ethanolamides) and their pharmacology , 2008, British journal of pharmacology.

[117]  S. Nakanishi,et al.  Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat , 1992, The Journal of comparative neurology.

[118]  C. Vaughan,et al.  Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray , 2008, Molecular Pharmacology.

[119]  B. Sakmann,et al.  Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy , 1993, Pflügers Archiv.

[120]  P. Ferrara,et al.  Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. , 1996, Biochimica et biophysica acta.

[121]  K. Mackie Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength , 2006, International Journal of Obesity.

[122]  M. Vekemans,et al.  The rat phospholipase Cβ 4 gene is expressed at high abundance in cerebellar Purkinje cells , 1995, Neuroreport.

[123]  Y. Usachev,et al.  All-or-None Ca2+ Release from Intracellular Stores Triggered by Ca2+ Influx through Voltage-Gated Ca2+ Channels in Rat Sensory Neurons , 1997, The Journal of Neuroscience.

[124]  L. Petrocellis,et al.  Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. , 1997, The Biochemical journal.

[125]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[126]  J. F. Krey,et al.  Endocannabinoids and related fatty acid derivatives in pain modulation. , 2002, Chemistry and physics of lipids.

[127]  Z. Song,et al.  CB1 cannabinoid receptor‐mediated neurite remodeling in mouse neuroblastoma N1E‐115 cells , 2001, Journal of neuroscience research.

[128]  I. Módy,et al.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations , 2000, The European journal of neuroscience.

[129]  M. Kano,et al.  Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors , 2001, Neuron.

[130]  Shiro Watanabe,et al.  Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes , 1994, Neurochemical Research.

[131]  R. Shigemoto,et al.  Differential expression of calretinin and metabotropic glutamate receptor mGluR1α defines subsets of unipolar brush cells in mouse cerebellum , 2002, The Journal of comparative neurology.

[132]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[133]  J. García-Sancho,et al.  Fura-2 antagonises calcium-induced calcium release. , 2003, Cell calcium.

[134]  T. Blackburn,et al.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.

[135]  A. Derbenev,et al.  Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve , 2004, The Journal of physiology.

[136]  V. Sandler,et al.  Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons , 1999, The Journal of Neuroscience.

[137]  Y. Kawaguchi,et al.  Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[138]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[139]  K. Svoboda,et al.  The Life Cycle of Ca2+ Ions in Dendritic Spines , 2002, Neuron.

[140]  D. Cota,et al.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance. , 2006, Endocrine reviews.

[141]  K. Mackie,et al.  Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[142]  A. Levey,et al.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[143]  T. Freund,et al.  Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala , 2004, The European journal of neuroscience.

[144]  M. Shen,et al.  Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures , 1996, The Journal of Neuroscience.

[145]  J. Bockaert,et al.  Functional coupling between ryanodine receptors and L-type calcium channels in neurons , 1996, Nature.

[146]  T. Bisogno,et al.  The endocannabinoid signalling system: Biochemical aspects , 2005, Pharmacology Biochemistry and Behavior.

[147]  Andreas Zimmer,et al.  The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells , 2002, The Journal of Neuroscience.

[148]  Y. Zilberter,et al.  Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex , 2000, The Journal of physiology.

[149]  Cherif Boudaba,et al.  Activity‐dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus , 2005, The Journal of physiology.

[150]  A. Hoffman,et al.  Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure , 2003, The Journal of Neuroscience.

[151]  M. Pistis,et al.  Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons , 2004, The Journal of Neuroscience.

[152]  H. Bradshaw,et al.  The expanding field of cannabimimetic and related lipid mediators , 2005, British journal of pharmacology.

[153]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[154]  Yannick Schwab,et al.  Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain , 2004, The Journal of physiology.

[155]  N. Sang,et al.  PGE2 glycerol ester, a COX‐2 oxidative metabolite of 2‐arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons , 2006, The Journal of physiology.

[156]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[157]  A. Lichtman,et al.  Evaluation of CB 1 Receptor Knockout Mice in the Morris Water Maze , 2002 .

[158]  R. Duvoisin,et al.  Retroinhibition of Presynaptic Ca2+ Currents by Endocannabinoids Released via Postsynaptic mGluR Activation at a Calyx Synapse , 2004, The Journal of Neuroscience.

[159]  B. Cravatt,et al.  The endogenous cannabinoid system and its role in nociceptive behavior. , 2004, Journal of neurobiology.

[160]  D. Lovinger,et al.  Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[161]  C. Stricker,et al.  The contribution of intracellular calcium stores to mEPSCs recorded in layer II neurones of rat barrel cortex , 2002, The Journal of physiology.

[162]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[163]  Y. Isomura,et al.  Distinct temporal profiles of activity‐dependent calcium increase in pyramidal neurons of the rat visual cortex , 1999, The Journal of physiology.

[164]  E. Levine,et al.  Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. , 2003, Journal of neurophysiology.

[165]  A. Lichtman,et al.  Evaluation of CB1 receptor knockout mice in the Morris water maze. , 2002, The Journal of pharmacology and experimental therapeutics.

[166]  Y. Kubota,et al.  Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex , 1994, Brain Research.

[167]  F. Crépel,et al.  Retrograde modulation of transmitter release by postsynaptic subtype 1 metabotropic glutamate receptors in the rat cerebellum , 2001, The Journal of physiology.

[168]  Judit K. Makara,et al.  Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.

[169]  Joseph E LeDoux Emotion circuits in the brain. , 2009, Annual review of neuroscience.

[170]  Eric D. Young,et al.  What's a cerebellar circuit doing in the auditory system? , 2004, Trends in Neurosciences.

[171]  I. Soltesz,et al.  Postsynaptic origin of CB1‐dependent tonic inhibition of GABA release at cholecystokinin‐positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus , 2007, The Journal of physiology.

[172]  K. Vinod,et al.  Role of the endocannabinoid system in depression and suicide. , 2006, Trends in pharmacological sciences.

[173]  D. Fegley,et al.  Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[174]  R. Malenka,et al.  Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus , 1992, Neuron.

[175]  V. Chapman,et al.  Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain , 2007, British journal of pharmacology.

[176]  K. Mackie,et al.  Short-Term Retrograde Inhibition of GABAergic Synaptic Currents in Rat Purkinje Cells Is Mediated by Endogenous Cannabinoids , 2002, The Journal of Neuroscience.

[177]  E. Ponomarev,et al.  Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.

[178]  Attila Losonczy,et al.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[179]  S. Almog,et al.  Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. , 1993, Journal of medicinal chemistry.

[180]  A. Lichtman,et al.  Endocannabinoids in cognition and dependence. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[181]  Yasuo Kawaguchi,et al.  Heterogeneity of phasic cholinergic signaling in neocortical neurons. , 2007, Journal of neurophysiology.

[182]  N. Stella Cannabinoid signaling in glial cells , 2004, Glia.

[183]  Yue Wang,et al.  Endocannabinoids facilitate the induction of LTP in the hippocampus , 2002, Nature Neuroscience.

[184]  N. Stella,et al.  ATP Induces a Rapid and Pronounced Increase in 2-Arachidonoylglycerol Production by Astrocytes, a Response Limited by Monoacylglycerol Lipase , 2004, The Journal of Neuroscience.

[185]  H. Eichenbaum Hippocampus Cognitive Processes and Neural Representations that Underlie Declarative Memory , 2004, Neuron.

[186]  Garrett E. Alexander Basal ganglia , 1998 .

[187]  B. Szabo,et al.  Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse , 2002, Neuroscience.

[188]  R. Hampson,et al.  Behaviorally relevant endocannabinoid action in hippocampus: dependence on temporal summation of multiple inputs , 2005, Behavioural pharmacology.

[189]  E. Hare,et al.  Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[190]  J. Morrow,et al.  The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[191]  F. Karush,et al.  Antibody affinity—III the role of multivalence , 1972 .

[192]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[193]  S. Itohara,et al.  Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice , 2006, Neurobiology of Disease.

[194]  D. Piomelli,et al.  Functional role of high-affinity anandamide transport, as revealed by selective inhibition. , 1997, Science.

[195]  S. Siegelbaum,et al.  Altered Presynaptic Vesicle Release and Cycling during mGluR-Dependent LTD , 2002, Neuron.

[196]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[197]  Y. Morozov,et al.  Post‐natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus , 2003, The European journal of neuroscience.

[198]  K. Harris,et al.  Three-Dimensional Relationships between Hippocampal Synapses and Astrocytes , 1999, The Journal of Neuroscience.

[199]  F. Crépel,et al.  Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents. , 2007, Journal of neurophysiology.

[200]  Afia B Ali,et al.  Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. , 2007, Journal of neurophysiology.

[201]  W. Regehr,et al.  Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells , 2003, The Journal of Neuroscience.

[202]  Alcino J. Silva,et al.  Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures , 2004, The Journal of Neuroscience.

[203]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[204]  P. Castillo,et al.  Heterosynaptic LTD of Hippocampal GABAergic Synapses A Novel Role of Endocannabinoids in Regulating Excitability , 2003, Neuron.

[205]  A. Lichtman,et al.  Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice , 2005, Psychopharmacology.

[206]  F. Fonseca,et al.  Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1 , 2008, Neuropharmacology.

[207]  R. Nitsch,et al.  The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.

[208]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors , 1985, Brain Research.

[209]  Susana R. Neves,et al.  Role of the Go/i signaling network in the regulation of neurite outgrowth. , 2006, Canadian journal of physiology and pharmacology.

[210]  H. Fukui,et al.  Postnatal expression of H1‐receptor mRNA in the rat brain: correlation to l‐histidine decarboxylase expression and local upregulation in limbic seizures , 1998, The European journal of neuroscience.

[211]  K. Mackie,et al.  Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation , 1999, Neuroscience.

[212]  Pierangelo Geppetti,et al.  An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[213]  D. Simone,et al.  Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons , 2004, The Journal of Neuroscience.

[214]  O. Valverde,et al.  Involvement of the endocannabinoid system in drug addiction , 2006, Trends in Neurosciences.

[215]  T. Bonner,et al.  Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. , 2000, European journal of pharmacology.

[216]  M. Kano,et al.  Endocannabinoid signalling triggered by NMDA receptor‐mediated calcium entry into rat hippocampal neurons , 2007, The Journal of physiology.

[217]  T. Tsumoto,et al.  Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus , 2008, Proceedings of the National Academy of Sciences.

[218]  F. Bermúdez-Silva,et al.  The endocannabinoid system: physiology and pharmacology. , 2005, Alcohol and alcoholism.

[219]  F. Rodríguez de Fonseca,et al.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat , 1997, Neuroreport.

[220]  A. Buriani,et al.  The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[221]  D. Talmage,et al.  Integration of Endocannabinoid and Leptin Signaling in an Appetite-Related Neural Circuit , 2005, Neuron.

[222]  J. Putney,et al.  The TRPC3/6/7 subfamily of cation channels. , 2003, Cell calcium.

[223]  B. Alger,et al.  Multiple mechanisms of endocannabinoid response initiation in hippocampus. , 2006, Journal of neurophysiology.

[224]  M. Isokawa,et al.  Ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus. , 2006, Journal of neurophysiology.

[225]  T. Hökfelt,et al.  Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[226]  C. Fowler Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. , 2004, Trends in pharmacological sciences.

[227]  A. Marty,et al.  Glutamate as a candidate retrograde messenger at interneurone‐Purkinje cell synapses of rat cerebellum. , 1996, The Journal of physiology.

[228]  P. Calabresi,et al.  Post-receptor mechanisms underlying striatal long-term depression , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[229]  H. Akil,et al.  Distribution of α 1a-, α 1b- and α 1d-adrenergic receptor mRNA in the rat brain and spinal cord , 1997, Journal of Chemical Neuroanatomy.

[230]  J. Vanderhaeghen,et al.  Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatum , 1992, Neuroscience Letters.

[231]  M. Kano,et al.  Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum , 2006, Neuroscience Research.

[232]  S. Haj-Dahmane,et al.  The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling , 2005, The Journal of Neuroscience.

[233]  M. Herkenham,et al.  Cannabinoid receptors undergo axonal flow in sensory nerves , 1999, Neuroscience.

[234]  T. Akita,et al.  Functional Triads Consisting of Ryanodine Receptors, Ca2+ Channels, and Ca2+-Activated K+ Channels in Bullfrog Sympathetic Neurons , 2000, The Journal of general physiology.

[235]  H. Markram,et al.  Regulation of Synaptic Efficacy by Coincidence of Postsynaptic APs and EPSPs , 1997, Science.

[236]  T. Freund,et al.  Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia , 2006, Neuroscience.

[237]  C. Funk,et al.  Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene , 1994, Nature.

[238]  T. Freund,et al.  GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus , 2000, Neuroscience.

[239]  W. Regehr,et al.  Differential Expression of Posttetanic Potentiation and Retrograde Signaling Mediate Target-Dependent Short-Term Synaptic Plasticity , 2007, Neuron.

[240]  A. Howlett,et al.  Pharmacology of cannabinoid receptors. , 1995, Annual review of pharmacology and toxicology.

[241]  J. Laitinen,et al.  Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. , 2007, Basic & clinical pharmacology & toxicology.

[242]  M. Kathmann,et al.  Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[243]  A. Levey,et al.  Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype- specific antibodies , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[244]  B. Alger,et al.  Calcium dependence of depolarization‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons , 1999, The Journal of physiology.

[245]  B. Alger,et al.  Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus , 1999, Neuroscience.

[246]  B. Sakmann,et al.  Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in rat barrel cortex , 1999, Nature Neuroscience.

[247]  D. Feldman,et al.  Timing-Based LTP and LTD at Vertical Inputs to Layer II/III Pyramidal Cells in Rat Barrel Cortex , 2000, Neuron.

[248]  S. Snyder,et al.  Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[249]  R. Hampson,et al.  Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. , 2003, Journal of neurophysiology.

[250]  L. Acsády,et al.  Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus , 1997, Neuroscience.

[251]  Alexandros Makriyannis,et al.  Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome , 2008, Physiology & Behavior.

[252]  R. Bertorelli,et al.  CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms , 2006, The European journal of neuroscience.

[253]  Wade G. Regehr,et al.  Endocannabinoids Control the Induction of Cerebellar LTD , 2005, Neuron.

[254]  A. Saghatelian,et al.  Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. , 2006, Biochemistry.

[255]  Judit K. Makara,et al.  Involvement of Nitric Oxide in Depolarization-Induced Suppression of Inhibition in Hippocampal Pyramidal Cells during Activation of Cholinergic Receptors , 2007, The Journal of Neuroscience.

[256]  Paul F. Smith,et al.  Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study , 2006, Neuroscience Letters.

[257]  F. Mascagni,et al.  Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons , 2001, Neuroscience.

[258]  S. McCune,et al.  Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain , 1993, Neuroscience.

[259]  H. Markram,et al.  Physiology and anatomy of synaptic connections between thick tufted pyramidal neurones in the developing rat neocortex. , 1997, The Journal of physiology.

[260]  R. Hampson,et al.  Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. , 1999, The Journal of pharmacology and experimental therapeutics.

[261]  K. Mackie,et al.  GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.

[262]  T. Freund,et al.  CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons , 2005, Neuroscience.

[263]  G. Riedel,et al.  Functions of cannabinoid receptors in the hippocampus , 2002, Neuropharmacology.

[264]  V. Marzo,et al.  Endocannabinoid control of food intake and energy balance , 2005, Nature Neuroscience.

[265]  M. Kano,et al.  Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures , 2000, Neuroscience Research.

[266]  Masaki Tanaka,et al.  Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist , 2006, Pain.

[267]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[268]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[269]  D. Linden,et al.  Expression of Cerebellar Long-Term Depression Requires Postsynaptic Clathrin-Mediated Endocytosis , 2000, Neuron.

[270]  P. Worley,et al.  COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[271]  M. Guzmán,et al.  Effects of cannabinoids on energy metabolism. , 1999, Life sciences.

[272]  S. File,et al.  Endocannabinoid system and stress and anxiety responses , 2005, Pharmacology Biochemistry and Behavior.

[273]  I. Yamamoto,et al.  Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. , 1997, Journal of biochemistry.

[274]  E. Marco,et al.  Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. , 2003, Pharmacology, biochemistry, and behavior.

[275]  T. Blackburn,et al.  Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system , 1997, Neuroscience.

[276]  L. Parsons,et al.  Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , 1999, Nature Neuroscience.

[277]  Marc Parmentier,et al.  Distribution of cannabinoid receptor messenger RNA in the human brain: An in situ hybridization histochemistry with oligonucleotides , 1992, Neuroscience Letters.

[278]  R Lujan,et al.  Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus , 1996, The European journal of neuroscience.

[279]  Anatol C. Kreitzer,et al.  Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells , 2001, Neuron.

[280]  山崎 美和子 Miniature synaptic events elicited by presynaptic Ca[2+] rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells , 2006 .

[281]  P. Jonas,et al.  Associative Long-Term Depression in the Hippocampus Is Dependent on Postsynaptic N-Type Ca2+ Channels , 2000, The Journal of Neuroscience.

[282]  L. Petrocellis,et al.  Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with Ionomycin , 1999, Journal of neurochemistry.

[283]  M. Ito,et al.  Cerebellar long-term depression: characterization, signal transduction, and functional roles. , 2001, Physiological reviews.

[284]  Yan-Yi Peng Ryanodine-Sensitive Component of Calcium Transients Evoked by Nerve Firing at Presynaptic Nerve Terminals , 1996, The Journal of Neuroscience.

[285]  E. Barker,et al.  Anandamide transport. , 2004, Pharmacology & therapeutics.

[286]  R. Mechoulam,et al.  CB 1 cannabinoid receptors are involved in neuroprotection via NF-jB inhibition , 2005 .

[287]  J. Sullivan,et al.  Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. , 1999, Journal of neurophysiology.

[288]  M. L. de Ceballos,et al.  Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2002, The Journal of Biological Chemistry.

[289]  A Konnerth,et al.  Release and sequestration of calcium by ryanodine‐sensitive stores in rat hippocampal neurones , 1997, The Journal of physiology.

[290]  S. Schiffmann,et al.  Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system , 1991, The Journal of comparative neurology.

[291]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[292]  S. Vandevoorde,et al.  The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out , 2007, Chemistry & biodiversity.

[293]  M. Poo,et al.  Modulation of GABAergic Transmission by Activity via Postsynaptic Ca2+-Dependent Regulation of KCC2 Function , 2005, Neuron.

[294]  D. Lovinger,et al.  Emerging roles for endocannabinoids in long‐term synaptic plasticity , 2003, British journal of pharmacology.

[295]  G. Buzsáki,et al.  Interneurons of the hippocampus , 1998, Hippocampus.

[296]  Masahiko Watanabe,et al.  Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals , 2008, The Journal of Neuroscience.

[297]  B. Connors,et al.  Sensory experience modifies the short-term dynamics of neocortical synapses , 1999, Nature.

[298]  L. Martin,et al.  Heterogeneous susceptibility of GABAA receptor‐mediated IPSCs to depolarization‐induced suppression of inhibition in rat hippocampus , 2001, The Journal of physiology.

[299]  B. Szabo,et al.  Effects of Exogenous and Endogenous Cannabinoids on GABAergic Neurotransmission between the Caudate-Putamen and the Globus Pallidus in the Mouse , 2006, Journal of Pharmacology and Experimental Therapeutics.

[300]  Carol A. Barnes,et al.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.

[301]  J. Vanderhaeghen,et al.  Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry , 1992, Neuroscience.

[302]  P. Somogyi,et al.  The cisternal organelle as a Ca2+-storing compartment associated with GABAergic synapses in the axon initial segment of hippocampal pyramidal neurones , 1994, Experimental Brain Research.

[303]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[304]  伊藤 正男 The cerebellum and neural control , 1984 .

[305]  S. Hestrin,et al.  Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors , 2004, The Journal of Neuroscience.

[306]  Y. Kubota,et al.  Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[307]  M. Barish,et al.  Inositol 1,4,5-trisphosphate and ryanodine receptor distributions and patterns of acetylcholine- and caffeine-induced calcium release in cultured mouse hippocampal neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[308]  E. J. Fletcher,et al.  Blockade by sigma site ligands of high voltage‐activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones , 1995, British journal of pharmacology.

[309]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[310]  B. Basavarajappa Critical enzymes involved in endocannabinoid metabolism. , 2007, Protein and peptide letters.

[311]  U. Misgeld,et al.  Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra , 2003, Neuroscience.

[312]  T. Freund,et al.  Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers , 2002, Neuropharmacology.

[313]  R. Pertwee GPR55: a new member of the cannabinoid receptor clan? , 2007, British journal of pharmacology.

[314]  T. Groblewski,et al.  Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models , 2003, The European journal of neuroscience.

[315]  K. Hsu,et al.  Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons , 2001, The Journal of physiology.

[316]  K. Mackie,et al.  Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain , 2006, Pain.

[317]  B. Bloch,et al.  Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[318]  I. Galve-Roperh,et al.  Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. , 1998, Molecular pharmacology.

[319]  E. Levine,et al.  Endocannabinoids Mediate Rapid Retrograde Signaling At Interneuron → Pyramidal Neuron Synapses of the Neocortex , 2003 .

[320]  F. Lenz,et al.  Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. , 2004, Brain research. Molecular brain research.

[321]  S. L. Patrick,et al.  Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity , 1998, Brain Research.

[322]  Mark M. Rasenick,et al.  Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.

[323]  E. Welker,et al.  Neurons immunoreactive for vasoactive intestinal polypeptide in the rat primary somatosensory cortex: Morphology and spatial relationship to barrel‐related columns , 2000, The Journal of comparative neurology.

[324]  S. Tonegawa,et al.  Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice , 1994, Cell.

[325]  R. Iyengar,et al.  Cannabinoid Receptor-induced Neurite Outgrowth Is Mediated by Rap1 Activation through Gαo/i-triggered Proteasomal Degradation of Rap1GAPII* , 2005, Journal of Biological Chemistry.

[326]  D. Piomelli,et al.  Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain , 1997, The Journal of Neuroscience.

[327]  M. Bear,et al.  Molecular mechanism for loss of visual cortical responsiveness following brief monocular deprivation , 2003, Nature Neuroscience.

[328]  K. Waku,et al.  Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[329]  S. Sherman,et al.  Ultrastructural Localization Suggests that Retinal and Cortical Inputs Access Different Metabotropic Glutamate Receptors in the Lateral Geniculate Nucleus , 1996, The Journal of Neuroscience.

[330]  T. Freund,et al.  Endocannabinoid transport tightly controls 2‐arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404 , 2004, The European journal of neuroscience.

[331]  M. Isokawa,et al.  Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell , 2005, The Journal of physiology.

[332]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.

[333]  John R. Huguenard,et al.  Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids , 2004, Nature.

[334]  U. Hellman,et al.  cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.

[335]  D. Lovinger,et al.  Retrograde Endocannabinoid Signaling in a Postsynaptic Neuron/Synaptic Bouton Preparation from Basolateral Amygdala , 2005, The Journal of Neuroscience.

[336]  C. Ledent,et al.  A role for endocannabinoids in indomethacin-induced spinal antinociception. , 2002, European journal of pharmacology.

[337]  D. Linden The expression of cerebellar LTD in culture is not associated with changes in AMPA-receptor kinetics, agonist affinity, or unitary conductance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[338]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[339]  B. May Role of the dorsal cochlear nucleus in the sound localization behavior of cats , 2000, Hearing Research.

[340]  Y. Kawaguchi,et al.  Selective cholinergic modulation of cortical GABAergic cell subtypes. , 1997, Journal of neurophysiology.

[341]  D. Fortin,et al.  Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. , 2004, Journal of neurophysiology.

[342]  Saori Oka,et al.  Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. , 2006, Progress in lipid research.

[343]  B. Alger Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids , 2002, Progress in Neurobiology.

[344]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[345]  R. Zucker,et al.  Photolysis‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons , 2001, The Journal of physiology.

[346]  R. Moratalla,et al.  Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia , 2003, Neuroscience.

[347]  W. Singer,et al.  Different voltage-dependent thresholds for inducing long-term depression and long-term potentiation in slices of rat visual cortex , 1990, Nature.

[348]  H. Markram,et al.  Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[349]  H. Monyer,et al.  Analysis of the effects of cannabinoids on identified synaptic connections in the caudate‐putamen by paired recordings in transgenic mice , 2006, The Journal of physiology.

[350]  D. Osei-Hyiaman,et al.  Evidence for novel cannabinoid receptors. , 2005, Pharmacology & therapeutics.

[351]  L. Petrocellis,et al.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain , 2006, Neuroscience.

[352]  W. Campbell,et al.  Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion , 1997, Journal of neurochemistry.

[353]  D. Piomelli,et al.  Structural determinants for recognition and translocation by the anandamide transporter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[354]  M. Brann,et al.  Localization of a family of muscarinic receptor mRNAs in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[355]  L. Hunyady,et al.  The Role of Diacylglycerol Lipase in Constitutive and Angiotensin AT1 Receptor-stimulated Cannabinoid CB1 Receptor Activity* , 2007, Journal of Biological Chemistry.

[356]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[357]  A. Hoffman,et al.  Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus , 2003, The European journal of neuroscience.

[358]  S. Tayebati,et al.  Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries , 2003, Neuroscience.

[359]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[360]  A. J. Lusis,et al.  Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. , 2001, Gene.

[361]  E. Levine,et al.  Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. , 2002, Journal of neurophysiology.

[362]  V. Pickel,et al.  Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus , 2001, The Journal of Neuroscience.

[363]  M. Kano,et al.  Endocannabinoids and Synaptic Function in the CNS , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[364]  G. Cossu,et al.  An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives , 2007, Brain Research Reviews.

[365]  T. Südhof,et al.  Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α , 2007, Neuron.

[366]  A Konnerth,et al.  Ryanodine receptor‐mediated intracellular calcium release in rat cerebellar Purkinje neurones. , 1995, The Journal of physiology.

[367]  Michela Matteoli,et al.  Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity , 2007, Science.

[368]  T. Kaneko,et al.  Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons. , 2007, Cerebral cortex.

[369]  D. Standaert,et al.  Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[370]  B. Alger,et al.  Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.

[371]  M. Notarnicola,et al.  Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population , 2007, International Journal of Obesity.

[372]  Masahiko Watanabe,et al.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[373]  K. Mackie,et al.  Cloning and molecular characterization of the rat CB2 cannabinoid receptor. , 2002, Biochimica et biophysica acta.

[374]  C. Vadász,et al.  Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens , 2003, Journal of neurochemistry.

[375]  Wade G. Regehr,et al.  Local Interneurons Regulate Synaptic Strength by Retrograde Release of Endocannabinoids , 2006, The Journal of Neuroscience.

[376]  M. J. Mattes,et al.  Binding parameters of antibodies reacting with multivalent antigens: functional affinity or pseudo-affinity. , 1997, Journal of immunological methods.

[377]  A. Hohmann,et al.  Endocannabinoid mechanisms of pain modulation , 2006, The AAPS Journal.

[378]  M. Elphick,et al.  The neurobiology and evolution of cannabinoid signalling. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[379]  K. Mackie,et al.  Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: A comparison between the gray mouse lemur (Microcebus murinus, primates) and rat , 2005, Neuroscience.

[380]  J. Rossier,et al.  AMPA receptor subunits expressed by single purkinje cells , 1992, Neuron.

[381]  D. P. Sutherland,et al.  Role of acoustic striae in hearing: discrimination of sound-source elevation , 1998, Hearing Research.

[382]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[383]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[384]  D. Dewitt,et al.  Characterization of inducible cyclooxygenase in rat brain , 1995, The Journal of comparative neurology.

[385]  M. Elphick,et al.  Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling , 2003, Neuroscience.

[386]  A. Barbáchano,et al.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.

[387]  A. Hoffman,et al.  Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus , 2000, The Journal of Neuroscience.

[388]  Robin Christensen,et al.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials , 2007, The Lancet.

[389]  T. Bonner,et al.  Localization of cannabinoid receptor mRNA in rat brain , 1993, The Journal of comparative neurology.

[390]  Patricia H Reggio,et al.  Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. , 2005, Life sciences.

[391]  S. McMahon,et al.  Cannabinoid CB(1) receptor expression in rat spinal cord. , 2000, Molecular and cellular neurosciences.

[392]  P. Belfrage,et al.  Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. , 1976, The Journal of biological chemistry.

[393]  B. Alger,et al.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others , 2008, Neuropharmacology.

[394]  F. Crépel,et al.  Developmental changes in agonist-induced retrograde signaling at parallel fiber-Purkinje cell synapses: role of calcium-induced calcium release. , 2007, Journal of neurophysiology.

[395]  S. Nelson,et al.  The NMDA-to-AMPA ratio at synapses onto layer 2/3 pyramidal neurons is conserved across prefrontal and visual cortices. , 2003, Journal of neurophysiology.

[396]  M. Elphick,et al.  Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry , 2003, Neuroscience.

[397]  D. Fortin,et al.  Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex , 2004, The Journal of physiology.

[398]  B. Alger,et al.  Retrograde signaling at GABAA-receptor synapses in the mammalian CNS , 1995, Trends in Neurosciences.

[399]  H. Kondo,et al.  Localization of mRNAs for three novel members (β3, β4 and γ2) of phospholipase C family in mature rat brain , 1994, Neuroscience Letters.

[400]  M. Herkenham,et al.  Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study , 2000 .

[401]  C. Flachskamm,et al.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. , 2003, The Journal of clinical investigation.

[402]  E. Valjent,et al.  Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence , 2002, Neuropharmacology.

[403]  S. Vicini,et al.  Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons , 1998, The Journal of physiology.

[404]  Pedro Grandes,et al.  Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex , 2007, PloS one.

[405]  Chiayu Q. Chiu,et al.  Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus , 2008, Neuropharmacology.

[406]  M. Bouthenet,et al.  A detailed mapping of hist amine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine , 1988, Neuroscience.

[407]  F. Crépel,et al.  Control of Ca2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K+ channels , 2001, The Journal of physiology.

[408]  D. O. Hebb,et al.  The organization of behavior , 1988 .

[409]  T. Freund,et al.  Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures , 2003, Neuron.

[410]  K. Waku,et al.  2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms , 1998, FEBS letters.

[411]  M. Kano,et al.  Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses , 2002, The Journal of Neuroscience.

[412]  P. Castillo,et al.  The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus , 2006, Neuroscience.

[413]  E. Milligan,et al.  Cannabinoids for the treatment of neuropathic pain: clinical evidence. , 2008, Current opinion in investigational drugs.

[414]  R F Thompson,et al.  Memory systems in the brain and localization of a memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[415]  S. Hjorth,et al.  The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.

[416]  R. Nicoll,et al.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses , 2001, Nature.

[417]  A. Howlett Efficacy in CB1 receptor‐mediated signal transduction , 2004, British journal of pharmacology.

[418]  B. Rocha,et al.  Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice , 2003, Behavioural pharmacology.

[419]  M. Low,et al.  Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids , 2005, The Journal of Neuroscience.

[420]  B. Robertson,et al.  Presynaptic internal Ca2+ stores contribute to inhibitory neurotransmitter release onto mouse cerebellar Purkinje cells , 2002, British journal of pharmacology.

[421]  C. Hansel,et al.  Climbing Fiber-Evoked Endocannabinoid Signaling Heterosynaptically Suppresses Presynaptic Cerebellar Long-Term Potentiation , 2006, The Journal of Neuroscience.

[422]  Z. Vogel,et al.  2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[423]  M. Diana,et al.  Group I Metabotropic Glutamate Receptors Inhibit GABA Release at Interneuron-Purkinje Cell Synapses through Endocannabinoid Production , 2004, The Journal of Neuroscience.

[424]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[425]  K. Mackie,et al.  Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.

[426]  D. Price,et al.  Cellular localizations of AMPA glutamate receptors within the basal forebrain magnocellular complex of rat and monkey , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[427]  Vanessa A. Bender,et al.  Two Coincidence Detectors for Spike Timing-Dependent Plasticity in Somatosensory Cortex , 2006, The Journal of Neuroscience.

[428]  F. Crépel,et al.  Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum , 2004, The Journal of physiology.

[429]  N. Ueda,et al.  Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners* , 2006, Journal of Biological Chemistry.

[430]  H. Markram,et al.  Dendritic calcium transients evoked by single back‐propagating action potentials in rat neocortical pyramidal neurons. , 1995, The Journal of physiology.

[431]  J. Rossier,et al.  Properties of bipolar VIPergic interneurons and their excitation by pyramidal neurons in the rat neocortex , 1998, The European journal of neuroscience.

[432]  K. Waku,et al.  Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. , 2000, Chemical & pharmaceutical bulletin.

[433]  L. Petrocellis,et al.  The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. , 2001, European journal of biochemistry.

[434]  M. Korbonits,et al.  The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System , 2008, PloS one.

[435]  J. Laitinen,et al.  An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors , 2003, British journal of pharmacology.

[436]  G. Chaudhuri,et al.  Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. , 1995, DNA sequence : the journal of DNA sequencing and mapping.

[437]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[438]  R. Hampson,et al.  Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.

[439]  T. Friede,et al.  Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis , 2005, Neurology.

[440]  Lei Wang,et al.  Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[441]  Masahiko Watanabe,et al.  Phospholipase Cβ3 is distributed in both somatodendritic and axonal compartments and localized around perisynapse and smooth endoplasmic reticulum in mouse Purkinje cell subsets , 2007, The European journal of neuroscience.

[442]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[443]  C. Salio,et al.  Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord , 2002, Neuroscience Letters.

[444]  S. Ben-Shabat,et al.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury , 2001, Nature.

[445]  R K Jain,et al.  Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. , 1992, Cancer research.

[446]  D. Prince,et al.  Cholinergic switching within neocortical inhibitory networks. , 1998, Science.

[447]  B. Sakmann,et al.  Spine Ca2+ Signaling in Spike-Timing-Dependent Plasticity , 2006, The Journal of Neuroscience.

[448]  P. Bregestovski,et al.  Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones , 2005, The Journal of physiology.

[449]  Masahiko Watanabe,et al.  Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.

[450]  G. Kunos,et al.  Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB 1 receptors on peripheral sympathetic nerves , 1996, British journal of pharmacology.

[451]  K. Mackie,et al.  Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones , 2005, The Journal of physiology.

[452]  W. Campbell,et al.  Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. , 2004, Molecular pharmacology.

[453]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[454]  J. Rossier,et al.  Classification of fusiform neocortical interneurons based on unsupervised clustering. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[455]  Masahiko Watanabe,et al.  Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain , 2000, Neuroscience Letters.

[456]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[457]  Y. Smith,et al.  Group I Metabotropic Glutamate Receptors in the Monkey Striatum: Subsynaptic Association with Glutamatergic and Dopaminergic Afferents , 2003, The Journal of Neuroscience.

[458]  L. Iversen,et al.  Cannabis and the brain. , 2003, Brain : a journal of neurology.

[459]  S. Thayer,et al.  Cannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture , 2001, The Journal of Neuroscience.

[460]  A. Brown Novel cannabinoid receptors , 2007, British journal of pharmacology.

[461]  M. Parmentier,et al.  Involvement of CB1 cannabinoid receptors in emotional behaviour , 2002, Psychopharmacology.

[462]  N. Jamshidi,et al.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.

[463]  A. Howlett,et al.  Cellular signal transduction by anandamide and 2-arachidonoylglycerol. , 2000, Chemistry and physics of lipids.

[464]  W. Regehr,et al.  Sustained Elevation of Dendritic Calcium Evokes Widespread Endocannabinoid Release and Suppression of Synapses onto Cerebellar Purkinje Cells , 2006, The Journal of Neuroscience.

[465]  D. Price,et al.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[466]  Anatol C. Kreitzer,et al.  Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum , 2005, The Journal of Neuroscience.

[467]  G. Bi,et al.  Synaptic Modifications in Cultured Hippocampal Neurons: Dependence on Spike Timing, Synaptic Strength, and Postsynaptic Cell Type , 1998, The Journal of Neuroscience.

[468]  A. Makriyannis,et al.  The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer* , 2005, Journal of Biological Chemistry.

[469]  C. Ledent,et al.  Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis , 2008, Journal of Neuroimmunology.

[470]  Alan Fine,et al.  Calcium Stores in Hippocampal Synaptic Boutons Mediate Short-Term Plasticity, Store-Operated Ca2+ Entry, and Spontaneous Transmitter Release , 2001, Neuron.

[471]  T. Mikkelsen,et al.  A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals* , 2006, Journal of Biological Chemistry.

[472]  Masahiko Watanabe,et al.  Roles of phospholipase Cβ and NMDA receptor in activity‐dependent endocannabinoid release , 2007, The Journal of physiology.

[473]  C. Ledent,et al.  Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test , 2003, The European journal of neuroscience.

[474]  David Robbe,et al.  Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens , 2008, Neuropharmacology.

[475]  S. Vandevoorde,et al.  Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro , 2007, British journal of pharmacology.

[476]  Michael Davis,et al.  Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear , 2005, Neuropsychopharmacology.

[477]  K. Mackie,et al.  Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.

[478]  R. Maldonado,et al.  Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain , 2007, Journal of neurochemistry.

[479]  L. Petrocellis,et al.  The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.

[480]  J. Penney,et al.  Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons , 1995, The Journal of comparative neurology.

[481]  Masahiko Watanabe,et al.  Gq protein α subunits Gαq and Gα11 are localized at postsynaptic extra‐junctional membrane of cerebellar Purkinje cells and hippocampal pyramidal cells , 2000, The European journal of neuroscience.

[482]  J. Špaček,et al.  Three-Dimensional analysis of dendritic spines , 1983, Anatomy and Embryology.

[483]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[484]  C. Seva,et al.  Cholecystokinin and gastrin receptors. , 2006, Physiological reviews.

[485]  J. Geiger,et al.  Presence and functional significance of presynaptic ryanodine receptors , 2003, Progress in Neurobiology.

[486]  P. Castillo,et al.  Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin , 2008, Proceedings of the National Academy of Sciences.

[487]  D. Piomelli The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[488]  A. Lichtman,et al.  Differential effects of Δ9-THC on spatial reference and working memory in mice , 2001, Psychopharmacology.

[489]  M. Elphick,et al.  Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1 , 2000, The Journal of comparative neurology.

[490]  M. Glass,et al.  CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[491]  P. Somogyi,et al.  Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1α, mGluR2 and mGluR5, relative to neurotransmitter release sites , 1997, Journal of Chemical Neuroanatomy.

[492]  K. Stratford,et al.  Presynaptic release probability influences the locus of long-term potentiation , 1992, Nature.

[493]  P. Robledo,et al.  Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration , 2005, Neuropsychopharmacology.

[494]  K. Perry,et al.  The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions , 2003, British journal of pharmacology.

[495]  J. Rossier,et al.  Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. , 2007, Journal of neurophysiology.

[496]  B. Alger,et al.  Differential effects of the group II mGluR agonist, DCG‐IV, on depolarization‐induced suppression of inhibition in hippocampal CA1 and CA3 neurons , 2000, Hippocampus.

[497]  D. Fortin,et al.  Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. , 2006, Cerebral cortex.

[498]  Masahiko Watanabe,et al.  Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area , 2008, Neuropharmacology.

[499]  Anatol C. Kreitzer,et al.  Mechanisms for Synapse Specificity during Striatal Long-Term Depression , 2007, The Journal of Neuroscience.

[500]  J. Girault,et al.  Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide , 1996, Science.

[501]  L. Forman The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801 , 2003, Brain Research Bulletin.

[502]  P. Castillo,et al.  Endocannabinoid-Mediated Metaplasticity in the Hippocampus , 2004, Neuron.

[503]  A. Levey,et al.  Differential presynaptic and postsynaptic expression of m1–m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse , 1998, Neuroscience.

[504]  E. Cudaback,et al.  Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells , 2007, The Journal of Neuroscience.

[505]  M. Herkenham,et al.  Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains , 1994, Neuroscience.

[506]  K. Mackie Cannabinoid receptor homo- and heterodimerization. , 2005, Life sciences.

[507]  A. Destexhe,et al.  The high-conductance state of neocortical neurons in vivo , 2003, Nature Reviews Neuroscience.

[508]  R. Treede,et al.  Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons , 2006, Neuroscience.

[509]  R. Miguel,et al.  Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters , 2001, Pharmacology Biochemistry and Behavior.

[510]  R. Elde,et al.  Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites , 1999, The European journal of neuroscience.

[511]  Shigetada Nakanishi,et al.  Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.

[512]  J. Parnavelas,et al.  Extensive co-existence of neuropeptides in the rat visual cortex , 1987, Brain Research.

[513]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[514]  Masahiko Watanabe,et al.  Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cβ in mouse brain , 1998, The European journal of neuroscience.

[515]  K. Mackie,et al.  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .

[516]  Anatol C. Kreitzer,et al.  Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids , 2001, The Journal of Neuroscience.

[517]  T. Freund,et al.  The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety , 2002, The European journal of neuroscience.

[518]  D. Lovinger,et al.  Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. , 2007, Journal of neurophysiology.

[519]  S. Oliet,et al.  Retrograde Regulation of GABA Transmission by the Tonic Release of Oxytocin and Endocannabinoids Governs Postsynaptic Firing , 2007, The Journal of Neuroscience.

[520]  A. Schoffelmeer,et al.  Cannabinoid CB1 receptors control conditioned drug seeking. , 2005, Trends in pharmacological sciences.

[521]  George Kunos,et al.  Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus , 2001, Neuron.

[522]  Masanobu Kano,et al.  Ca2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities , 2007, Current Opinion in Neurobiology.

[523]  R. Llinás,et al.  Different calcium channels mediate transmitter release evoked by transient or sustained depolarization at mammalian symphatetic ganglia , 1995, Neuroscience.

[524]  E. V. Bockstaele,et al.  Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex , 2005, Brain Research.

[525]  L. Trussell,et al.  Cell-specific, spike timing–dependent plasticities in the dorsal cochlear nucleus , 2004, Nature Neuroscience.

[526]  Anatol C. Kreitzer,et al.  Retrograde signaling by endocannabinoids , 2002, Current Opinion in Neurobiology.

[527]  D. Faber,et al.  Applicability of the coefficient of variation method for analyzing synaptic plasticity. , 1991, Biophysical journal.

[528]  M. Parmentier,et al.  Nucleotide sequence of a human cannabinoid receptor cDNA. , 1990, Nucleic acids research.

[529]  K. Waku,et al.  2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. , 2002, Archives of biochemistry and biophysics.

[530]  D. Lovinger,et al.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum , 2002, Nature Neuroscience.

[531]  M. Whittington,et al.  A Novel Network of Multipolar Bursting Interneurons Generates Theta Frequency Oscillations in Neocortex , 2003, Neuron.

[532]  M. Kano,et al.  Endogenous Cannabinoid Signaling through the CB1 Receptor Is Essential for Cerebellum-Dependent Discrete Motor Learning , 2006, The Journal of Neuroscience.

[533]  K. Mackie,et al.  Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk? , 2005, Molecular Pharmacology.

[534]  R. Gibbs,et al.  A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide* , 2004, Journal of Biological Chemistry.

[535]  N. Ueda,et al.  Biosynthetic Pathways of the Endocannabinoid Anandamide , 2007, Chemistry & biodiversity.

[536]  K. Waku,et al.  Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species , 2003, Journal of neurochemistry.

[537]  D. Uhlrich,et al.  Muscarinic receptor subtypes in the lateral geniculate nucleus: A light and electron microscopic analysis , 1999, The Journal of comparative neurology.

[538]  A. Makriyannis,et al.  How lipophilic cannabinergic ligands reach their receptor sites. , 2005, Prostaglandins & other lipid mediators.

[539]  A. Marty,et al.  Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE) , 2004, British journal of pharmacology.

[540]  A. Araque,et al.  Endocannabinoids Mediate Neuron-Astrocyte Communication , 2008, Neuron.

[541]  B. Cravatt,et al.  Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300475-JLR200 , 2004, Journal of Lipid Research.

[542]  F. Drago,et al.  Endocannabinoids and neurodegenerative diseases. , 2007, Pharmacological research.

[543]  Q. Pittman,et al.  Talking back: dendritic neurotransmitter release , 2003, Trends in Neurosciences.

[544]  S. Nigam,et al.  Biochemistry and pharmacology of endovanilloids. , 2007, Pharmacology & therapeutics.

[545]  T. Tsumoto,et al.  Roles of Endocannabinoids in Heterosynaptic Long-Term Depression of Excitatory Synaptic Transmission in Visual Cortex of Young Mice , 2008, The Journal of Neuroscience.

[546]  D. Centonze,et al.  Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons , 2007, Molecular and Cellular Neuroscience.

[547]  E. Tzavara,et al.  A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. , 2005, Trends in pharmacological sciences.

[548]  R. Nicoll,et al.  Two Distinct Forms of Long-Term Depression Coexist in CA1 Hippocampal Pyramidal Cells , 1997, Neuron.

[549]  Sean P. Brown,et al.  Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. , 1997, Journal of neurophysiology.

[550]  M. Häring,et al.  Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice , 2007, Neuroscience.

[551]  Beat Lutz,et al.  Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling , 2004, The Journal of Neuroscience.

[552]  L. Cooper,et al.  A unified model of NMDA receptor-dependent bidirectional synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[553]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[554]  E. B. Roberts,et al.  Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret. , 1999, Journal of neurophysiology.

[555]  M. Elphick,et al.  Localization of N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on N‐acylethanolamines as neural signaling molecules , 2008, The Journal of comparative neurology.

[556]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[557]  P. Casellas,et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[558]  Y. Kawaguchi,et al.  Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex. , 1993, Journal of neurophysiology.

[559]  G. Augustine,et al.  Local Calcium Signaling in Neurons , 2003, Neuron.

[560]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[561]  Robert C. Malenka,et al.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.

[562]  M. Kano,et al.  Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation , 2002, The European journal of neuroscience.

[563]  B. Salzberg,et al.  Caffeine interaction with fluorescent calcium indicator dyes. , 1999, Biophysical journal.

[564]  D. Lovinger,et al.  Disruption of Endocannabinoid Release and Striatal Long-Term Depression by Postsynaptic Blockade of Endocannabinoid Membrane Transport , 2004, The Journal of Neuroscience.

[565]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[566]  Niklas Larsson,et al.  Identification and characterisation of a novel splice variant of the human CB1 receptor , 2005, FEBS letters.

[567]  D. Linden,et al.  Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. , 2000, Journal of neurophysiology.

[568]  B. Alger,et al.  N‐ and L‐type calcium channel involvement in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells , 1998, The Journal of physiology.

[569]  Henry H. Yin,et al.  Dopaminergic Control of Corticostriatal Long-Term Synaptic Depression in Medium Spiny Neurons Is Mediated by Cholinergic Interneurons , 2006, Neuron.

[570]  P. Delmas,et al.  Signaling Microdomains Define the Specificity of Receptor-Mediated InsP3 Pathways in Neurons , 2002, Neuron.

[571]  C. Ramesha,et al.  Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.

[572]  S. Snyder,et al.  Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. , 1987, The Journal of biological chemistry.

[573]  Edith Hamel,et al.  5-HT3 Receptors Mediate Serotonergic Fast Synaptic Excitation of Neocortical Vasoactive Intestinal Peptide/Cholecystokinin Interneurons , 2002, The Journal of Neuroscience.

[574]  N. Sang,et al.  COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity , 2007, Journal of neurochemistry.

[575]  K. Deisseroth,et al.  CREB Phosphorylation and Dephosphorylation: A Ca2+- and Stimulus Duration–Dependent Switch for Hippocampal Gene Expression , 1996, Cell.

[576]  Paul Antoine Salin,et al.  Cyclic AMP Mediates a Presynaptic Form of LTP at Cerebellar Parallel Fiber Synapses , 1996, Neuron.

[577]  Masanobu Kano,et al.  Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum , 2005, The Journal of Neuroscience.

[578]  A. Marty,et al.  Neighboring cerebellar purkinje cells communicate via retrograde inhibition of common presynaptic interneurons , 1993, Neuron.

[579]  S. Gaetani,et al.  Anandamide hydrolysis: a new target for anti-anxiety drugs? , 2003, Trends in molecular medicine.

[580]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[581]  Beat Lutz,et al.  Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes , 2006, The Journal of Neuroscience.

[582]  Y. Jan,et al.  Changing subunit composition of heteromeric NMDA receptors during development of rat cortex , 1994, Nature.

[583]  Ken Mackie,et al.  Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.

[584]  Greg D. Gale,et al.  Hippocampus and contextual fear conditioning: Recent controversies and advances , 2001, Hippocampus.

[585]  B. Lutz,et al.  Further evidence for the existence of a specific process for the membrane transport of anandamide. , 2004, The Biochemical journal.

[586]  D. Lovinger,et al.  Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling , 2008, Neuropharmacology.

[587]  Wade G. Regehr,et al.  Timing dependence of the induction of cerebellar LTD , 2008, Neuropharmacology.

[588]  J. Liebeskind,et al.  Opioid and nonopioid mechanisms of stress analgesia. , 1980, Science.

[589]  Yasuo Kawaguchi,et al.  Two distinct subgroups of cholecystokinin-immunoreactive cortical interneurons , 1997, Brain Research.

[590]  David Robbe,et al.  Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[591]  P. J. Sjöström,et al.  Endocannabinoid-dependent neocortical layer-5 LTD in the absence of postsynaptic spiking. , 2004, Journal of neurophysiology.

[592]  I. Lizasoain,et al.  The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats , 2007, Pediatric Research.

[593]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[594]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[595]  P. Soubrié,et al.  Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. , 2000, Journal of neurophysiology.

[596]  C. Frazier,et al.  Endocannabinoid-mediated depolarization-induced suppression of inhibition in hilar mossy cells of the rat dentate gyrus. , 2006, Journal of neurophysiology.

[597]  S. Goldberg,et al.  Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences , 2004, Neuroreport.

[598]  Mariko Miyata,et al.  Deficient long‐term synaptic depression in the rostral cerebellum correlated with impaired motor learning in phospholipase C β4 mutant mice , 2001, The European journal of neuroscience.

[599]  M. Pistis,et al.  Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors , 2004, The Journal of Neuroscience.

[600]  D. Piomelli,et al.  RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol , 2004, Molecular Pharmacology.

[601]  C. Salio,et al.  Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord , 2002, Neuroscience.

[602]  M. Herkenham,et al.  Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. , 2000, Synapse.

[603]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[604]  I. McGregor,et al.  The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol , 2004, Brain Research.

[605]  W. Wetsel,et al.  Regulation of gonadotropin-releasing hormone secretion by cannabinoids. , 2005, Endocrinology.

[606]  B. Martin,et al.  Cannabis: pharmacology and toxicology in animals and humans. , 1996, Addiction.

[607]  Yuri Zilberter,et al.  Endocannabinoid-Independent Retrograde Signaling at Inhibitory Synapses in Layer 2/3 of Neocortex: Involvement of Vesicular Glutamate Transporter 3 , 2004, The Journal of Neuroscience.

[608]  R. Hampson,et al.  Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons. , 1995, Life sciences.

[609]  Pierre Casellas,et al.  Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor , 2003, Journal of Biological Chemistry.

[610]  C. Fowler The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action , 2007, British journal of pharmacology.

[611]  K. Mackie,et al.  Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input‐specific retrograde signalling by cholinergic neurons , 2003, The European journal of neuroscience.

[612]  F. Bymaster,et al.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.

[613]  T. Möller,et al.  P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[614]  M. Kano,et al.  Phospholipase cbeta4 is specifically involved in climbing fiber synapse elimination in the developing cerebellum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[615]  Y. Dan,et al.  Spike Timing-Dependent Plasticity of Neural Circuits , 2004, Neuron.

[616]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[617]  A. Molleman,et al.  Cannabinoid signalling. , 2006, Life sciences.

[618]  M. Millan,et al.  The neurobiology and control of anxious states , 2003, Progress in Neurobiology.

[619]  R. Prediger,et al.  The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats , 2006, Psychopharmacology.

[620]  M. Bear,et al.  Homosynaptic long-term depression in the visual cortex , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[621]  Vanessa A. Bender,et al.  Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex , 2007, Neuroscience.

[622]  A. Marty,et al.  Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents , 1991, Neuron.

[623]  J. Rossier,et al.  Selective Excitation of Subtypes of Neocortical Interneurons by Nicotinic Receptors , 1999, The Journal of Neuroscience.

[624]  Wade G. Regehr,et al.  Associative Short-Term Synaptic Plasticity Mediated by Endocannabinoids , 2005, Neuron.

[625]  Y. Dan,et al.  Spike-timing-dependent synaptic modification induced by natural spike trains , 2002, Nature.

[626]  A. Burkhalter,et al.  Three distinct families of GABAergic neurons in rat visual cortex. , 1997, Cerebral cortex.

[627]  M. C. Angulo,et al.  Molecular and Physiological Diversity of Cortical Nonpyramidal Cells , 1997, The Journal of Neuroscience.

[628]  M. Pistis,et al.  Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons , 2006, The European journal of neuroscience.

[629]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[630]  T. Freund,et al.  Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus , 2001, Neuroscience.

[631]  D. Deutsch,et al.  Evidence against the presence of an anandamide transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[632]  R. Puffenbarger,et al.  Genetic Polymorphisms of the Endocannabinoid System , 2007, Chemistry & biodiversity.

[633]  S. Di,et al.  Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism , 2003, The Journal of Neuroscience.

[634]  Alberto Rábano,et al.  Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains , 2003, The Journal of Neuroscience.

[635]  S. Kirov,et al.  Evidence for Metabotropic Glutamate Receptor Activation in the Induction of Depolarization-Induced Suppression of Inhibition in Hippocampal CA1 , 1998, The Journal of Neuroscience.

[636]  David Robbe,et al.  Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens , 2001, The Journal of Neuroscience.

[637]  P. Beaulieu,et al.  The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. , 2007, European journal of pharmacology.

[638]  Tamás F. Freund,et al.  CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2 , 2008, Neuropharmacology.

[639]  P. Soubrié,et al.  Cannabinoids decrease excitatory synaptic transmission and impair long‐term depression in rat cerebellar Purkinje cells , 1998, The Journal of physiology.

[640]  Ivan Soltesz,et al.  Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures , 2007, The Journal of Neuroscience.

[641]  R. Spencer,et al.  Immunohistochemical localization of the neural cannabinoid receptor in rat brain , 1998, Journal of neuroscience research.

[642]  H. Ujike,et al.  New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.

[643]  J. Walker,et al.  Pain modulation by release of the endogenous cannabinoid anandamide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[644]  M. Staufenbiel,et al.  Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera , 1995, Neuropharmacology.

[645]  M. Pistis,et al.  Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study , 2002, Brain Research.

[646]  J. Schwartz,et al.  Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates , 1990, Brain Research.

[647]  A. Argiolas,et al.  Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: Immunocytochemistry, autoradiography and behavioral studies , 2007, Neuroscience.

[648]  M. Kano,et al.  Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus , 2003, The European journal of neuroscience.

[649]  P. J. Sjöström,et al.  Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors , 2003, Neuron.

[650]  P. Casellas,et al.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. , 1995, The Biochemical journal.

[651]  N. Birdsall,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[652]  J. Palacios,et al.  Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry , 1990, Neuroscience Letters.

[653]  J. Laitinen,et al.  URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. , 2006, Chemistry & biology.

[654]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[655]  Jennifer A. Geaga,et al.  URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. , 2007, Chemistry & biology.

[656]  P. Kostyuk,et al.  Calcium stores in neurons and glia , 1994, Neuroscience.

[657]  B. Alger,et al.  Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus , 2001, The Journal of Neuroscience.

[658]  Craig Weiss,et al.  Hippocampal lesions prevent trace eyeblink conditioning in the freely moving rat , 1999, Behavioural Brain Research.

[659]  M. Herkenham,et al.  Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study , 1999, Neuroscience.

[660]  J. Laitinen,et al.  Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. , 2004, Biochemical pharmacology.

[661]  G. Griffin,et al.  Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. , 2000, The Journal of pharmacology and experimental therapeutics.

[662]  Y. Kubota,et al.  Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. , 1993, Journal of neurophysiology.

[663]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[664]  D. Lovinger,et al.  Induction of striatal long‐term synaptic depression by moderate frequency activation of cortical afferents in rat , 2005, The Journal of physiology.

[665]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[666]  A. Levey,et al.  Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[667]  M. Kano,et al.  mGluR1 in cerebellar Purkinje cells is required for normal association of temporally contiguous stimuli in classical conditioning , 2002, The European journal of neuroscience.

[668]  T. Bonner,et al.  A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. , 1996, Molecular pharmacology.

[669]  D. Lovinger,et al.  Decreased Frequency But Not Amplitude of Quantal Synaptic Responses Associated with Expression of Corticostriatal Long-Term Depression , 1997, The Journal of Neuroscience.

[670]  V. Marzo,et al.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol , 2002, British journal of pharmacology.

[671]  Ian Duguid,et al.  Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron–Purkinje cell synapses , 2004, Nature Neuroscience.

[672]  S. Kawahara,et al.  Impaired delay but normal trace eyeblink conditioning in PLCβ4 mutant mice , 2001, Neuroreport.

[673]  M. Ussher,et al.  Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[674]  Michael Fill,et al.  Ryanodine receptor calcium release channels. , 2002, Physiological reviews.

[675]  A. Marty,et al.  Presynaptic Ryanodine-Sensitive Calcium Stores Contribute to Evoked Neurotransmitter Release at the Basket Cell-Purkinje Cell Synapse , 2003, The Journal of Neuroscience.

[676]  M. Kano,et al.  Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals , 2001, Neuron.

[677]  G. Wang,et al.  An R-Type Ca2+ Current in Neurohypophysial Terminals Preferentially Regulates Oxytocin Secretion , 1999, The Journal of Neuroscience.

[678]  R. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors. , 1997, Pharmacology & therapeutics.

[679]  A. Molleman,et al.  Cannabinoid signalling (review) , 2006 .

[680]  C. Vaughan,et al.  Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling , 2008, The Journal of Neuroscience.

[681]  John A. Peters,et al.  The 5-HT3B subunit is a major determinant of serotonin-receptor function , 1999, Nature.

[682]  B. Alger,et al.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[683]  R. E. Brown,et al.  Cannabinoid modulation of rat pup ultrasonic vocalizations. , 1996, European journal of pharmacology.

[684]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[685]  P. Somogyi,et al.  Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization , 1994, Neuroscience.

[686]  Tiziana Bisogno,et al.  Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol , 2006, The Journal of physiology.

[687]  M. Kano,et al.  Miniature Synaptic Events Elicited by Presynaptic Ca2+ Rise Are Selectively Suppressed by Cannabinoid Receptor Activation in Cerebellar Purkinje Cells , 2006, The Journal of Neuroscience.

[688]  Y. Kawaguchi Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[689]  L. Trussell,et al.  Coactivation of Pre- and Postsynaptic Signaling Mechanisms Determines Cell-Specific Spike-Timing-Dependent Plasticity , 2007, Neuron.

[690]  Ken Mackie,et al.  Endocannabinoid Signaling in Rat Somatosensory Cortex: Laminar Differences and Involvement of Specific Interneuron Types , 2005, The Journal of Neuroscience.

[691]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[692]  E. Onaivi Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain , 2007, Neuropsychobiology.

[693]  B. Gorzalka,et al.  Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test , 2005, European Neuropsychopharmacology.

[694]  S. McMahon,et al.  Cannabinoid CB1 Receptor Expression in Rat Spinal Cord , 2000, Molecular and Cellular Neuroscience.

[695]  D. Selley,et al.  Inhibitory effects of SR141716A on G-protein activation in rat brain. , 2001, European journal of pharmacology.

[696]  K. Jin,et al.  Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures , 1999, The Journal of Neuroscience.

[697]  D. Piomelli,et al.  Control of pain initiation by endogenous cannabinoids , 1998, Nature.

[698]  P. Somogyi,et al.  Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[699]  C. Fowler,et al.  Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[700]  C. Glass,et al.  The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit* , 1999, The Journal of Biological Chemistry.

[701]  D. Centonze,et al.  Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum , 2008, Nature Neuroscience.

[702]  E. Falkenstein,et al.  Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. , 2000, Pharmacological reviews.

[703]  Z. Bashir,et al.  Different forms of LTD in the CA1 region of the hippocampus: role of age and stimulus protocol , 2000, The European journal of neuroscience.

[704]  Masahiko Watanabe,et al.  Distribution of type 1 cannabinoid receptor (CB1)‐immunoreactive axons in the mouse hypothalamus , 2007, The Journal of comparative neurology.

[705]  D. Baker,et al.  In silico patent searching reveals a new cannabinoid receptor. , 2006, Trends in pharmacological sciences.

[706]  B. Alger,et al.  Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism , 1994, Neuron.

[707]  I. Díaz-Laviada,et al.  Signal transduction activated by cannabinoid receptors. , 2005, Mini reviews in medicinal chemistry.

[708]  J. Palacios,et al.  The distribution of histamine H1-receptors in the rat brain: An autoradiographic study , 1981, Neuroscience.

[709]  Masahiko Watanabe,et al.  Predominant expression of phospholipase Cβ1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements , 2008, The European journal of neuroscience.

[710]  G. Shepherd The Synaptic Organization of the Brain , 1979 .

[711]  D. Muller,et al.  A simple method for organotypic cultures of nervous tissue , 1991, Journal of Neuroscience Methods.

[712]  L. Acsády,et al.  Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission , 2001, The Journal of Neuroscience.